USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$308.50K
Market Cap
-
P/E Ratio
-0.03
EPS
$3.00
52 Week High
$0.00
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$8.2M |
Total Revenue | $7.2M |
Cost Of Revenue | $15M |
Costof Goods And Services Sold | $15M |
Operating Income | -$50M |
Selling General And Administrative | $26M |
Research And Development | $14M |
Operating Expenses | $41M |
Investment Income Net | - |
Net Interest Income | -$5.7M |
Interest Income | - |
Interest Expense | $5.3M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $859K |
Income Before Tax | -$50M |
Income Tax Expense | $691K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$50M |
Comprehensive Income Net Of Tax | - |
Ebit | -$45M |
Ebitda | -$44M |
Net Income | -$50M |
Field | Value (USD) |
---|---|
Total Assets | $35M |
Total Current Assets | $25M |
Cash And Cash Equivalents At Carrying Value | $16M |
Cash And Short Term Investments | $16M |
Inventory | $4.8M |
Current Net Receivables | $1.4M |
Total Non Current Assets | $9.6M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $3.3M |
Other Non Current Assets | - |
Total Liabilities | $63M |
Total Current Liabilities | $56M |
Current Accounts Payable | $1.5M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $43M |
Total Non Current Liabilities | $6.7M |
Capital Lease Obligations | $8.2M |
Long Term Debt | - |
Current Long Term Debt | $41M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $49M |
Other Current Liabilities | $12M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$28M |
Treasury Stock | - |
Retained Earnings | -$584M |
Common Stock | $4K |
Common Stock Shares Outstanding | $2.6M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$48M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $859K |
Capital Expenditures | $192K |
Change In Receivables | - |
Change In Inventory | -$744K |
Profit Loss | - |
Cashflow From Investment | -$192K |
Cashflow From Financing | $53M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$50M |
Field | Value (USD) |
---|---|
Gross Profit | -$8.2M |
Total Revenue | $7.2M |
Cost Of Revenue | $15M |
Costof Goods And Services Sold | $15M |
Operating Income | -$50M |
Selling General And Administrative | $26M |
Research And Development | $14M |
Operating Expenses | $41M |
Investment Income Net | - |
Net Interest Income | -$5.7M |
Interest Income | - |
Interest Expense | $5.3M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $859K |
Income Before Tax | -$50M |
Income Tax Expense | $691K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$50M |
Comprehensive Income Net Of Tax | - |
Ebit | -$45M |
Ebitda | -$44M |
Net Income | -$50M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
T2 Biosystems, Inc., an in vitro diagnostic company, develops diagnostic products and candidate products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.